Levofloxacin 25 MG/ML solution 200ML
Ended Awarded
- Contract number
- SPE2DR26FQP3W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,728
Award facts
- Contract value 100% obligated
- $1,728.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,728.20 to AmerisourceBergen Drug Corp for the supply of Levofloxacin 25 mg/mL solution in 200 mL quantities. The contract, awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's selection through competitive procurement for this and other federal contracts demonstrates its capability to meet stringent federal requirements. The levofloxacin delivery under this order supports military healthcare operations by providing an essential broad-spectrum antibiotic used across Defense Health Agency and other government healthcare systems. This contract exemplifies the company's role as a flexible and comprehensive medical supply partner within the DLA's strategic pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26FQP3W?
SPE2DR26FQP3W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FQP3W worth?
The government has obligated $1,728 on SPE2DR26FQP3W.
Is contract SPE2DR26FQP3W an order under another contract?
Yes. SPE2DR26FQP3W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP3W competed?
The extent of competition for SPE2DR26FQP3W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award